跳至主要内容
临床试验/JPRN-jRCTs041220082
JPRN-jRCTs041220082招募中Unknown

Evaluation of usefulness of plasma arginine vasopressin measurement in arginine-stimulating test for diagnosis of central diabetes insipidus

Arima Hiroshi0 个研究点目标入组 50 人开始时间: 2022年10月26日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
Arima Hiroshi
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 18age old 至 ot applicable(—)
性别
All

入选标准

  • Patients below who consent to participate in this study in writing
  • 1. Patients suspected as central diabetes insipidus
  • 2. Patients already diagnosed as central diabetes insipidus
  • 3. Patients with diencephalohypophysial diseases and no symptoms of diabetes insipidus

排除标准

  • 1. Patients with heart and renal failure
  • 2. Patients with bronchial asthma
  • Pregnant or breastfeeding patients
  • 3. Patients considered inappropriate for the participation in this study by doctors

研究者

发起方
Arima Hiroshi

相似试验

已完成
不适用
Evaluation of plasma arginine vasopressin in hypertonic saline test in patients with diencephalohypophysial diseasesDiabetes insipidus
JPRN-UMIN000020112Department of Endocrinology and Diabetes, Nagoya Graduate School of Medicine20
进行中(未招募)
1 期
Arginin Vasopressin im fortgeschrittenen vasodilatorischen Schock: Ein Dosisvergleich 2 vs. 4 IU/h5. Einschlusskriterien5.1. Patienten mit vasodilatorischem Schock aufgrund:a) Sepsis [Definitionen gemäss den Empfehlungen der ACCP/SCCM (12)]b) SIRS [Definitionen gemäss den Empfehlungen der ACCP/SCCM (12)]c) SIRS nach herzchirurgischen Eingriffen mit Verwendung der Herzlungen-Maschine5.2. Hypotonie (MAP <60 mmHg) trotz5.3. Noradrenalinbedarf >0,6 µg/kg/min zur Erreichung eines MAP >60 mmHgMedDRA version: 9.1Level: LLTClassification code 10021118Term: Hypotonia
EUCTR2007-005010-40-ATniv.-Prof. Dr. Volker Wenzel50
招募中
1 期
Arginine effect on height growth of childre
IRCT20230603058376N1Ardabil University of Medical Sciences76
招募中
4 期
To observe safety of Vasograin (a combination of Ergotamine, Paracetamol, Prochlorperazine, and Caffeine) for treating migraines in adults: an open study where all participants receive the same treatment.
CTRI/2024/06/068686Cadila Pharmaceuticals Ltd.1,000
进行中(未招募)
1 期
Effect of low-dose arginine-vasopressin supplementation on post-transplant Acute Kidney Injury after liver transplantation - AVENIR TrialAcute Kidney Injury, Liver transplantationMedDRA version: 21.0Level: LLTClassification code: 10024716Term: Liver transplantation Class: 10042613MedDRA version: 21.1Level: LLTClassification code: 10000821Term: Acute kidney failure Class: 10038359
CTIS2023-506512-40-00Assistance Publique Hopitaux De Paris304